Prognosis: Coronavirus-logo

Prognosis: Coronavirus

Bloomberg News

Harnessing Bloomberg's reporting from every continent, Bloomberg's Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptations they are making in the face of the global pandemic. Come back weekday afternoons for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world.

Harnessing Bloomberg's reporting from every continent, Bloomberg's Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptations they are making in the face of the global pandemic. Come back weekday afternoons for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world.

Location:

United States

Description:

Harnessing Bloomberg's reporting from every continent, Bloomberg's Prognosis podcast brings the news, data and analysis you need for living in the time of Covid-19. In around ten minutes, we will explain the latest developments in health and science, the impact on individuals, industries and governments and the adaptations they are making in the face of the global pandemic. Come back weekday afternoons for a short dose of the best information about the novel coronavirus from more than 120 bureaus around the world.

Language:

English


Episodes

Can We Fix the Chaotic Vaccine Rollout?

1/15/2021
An accelerating rush to give coronavirus vaccines to Americans has caused confusion over who can get a shot when. And the difficulty getting shots -- or even information about the vaccine -- is complicating the push toward widespread immunity. Michelle Fay Cortez reports on what’s gone wrong with the vaccine rollout so far, and whether the upcoming Biden administration’s plans will improve it.

Duration:00:16:20

Why Healthcare Workers Refuse the Vaccine

1/13/2021
Most states have prioritized health-care workers in their vaccination programs. But across the country, vaccine providers are finding that some of those workers don’t want the shot. Nurses and firefighters are among those questioning its safety after approval in record time. Elise Young reports that reluctance to get the shot that could end the pandemic goes well beyond anti-vax activists who spout unproven theories on social media.

Duration:00:15:09

What Allergic Vaccine Reactions Mean For You

1/11/2021
As vaccinations roll out across the country, a few people have incurred serious allergic reactions. Though the rate is very low, it is still higher than that for the seasonal flu vaccine. Despite that, the CDC is sticking with its recommendation that most people should still get the shots. Emma Court explains why.

Duration:00:13:02

The U.K. Health System Threatens to Buckle

1/8/2021
The United Kingdom’s national health system is in danger of breaking under the weight of its raging Coronavirus outbreak, and the next few weeks will be its biggest challenge yet. The death toll is the highest in Europe and daily infections are at a record. Medical staff say they may be forced to turn people away from hospitals if the latest lockdown fails to stop the spread quickly enough. James Paton reports from London on the fast-spreading new virus strain and the next crucial weeks for...

Duration:00:16:07

Vaccines via Eventbrite

1/6/2021
As states struggle to piece together vaccine strategies without a coordinated national plan, some have resorted to web-based technology for logistical support. The result: they’re lining up appointments using software that’s better suited for arranging volleyball meetups than a historic public health campaign.

Duration:00:15:08

Vaccinating the Worst-Hit Southeast Asian Country

1/4/2021
Indonesia had planned to prioritize its working-age population for its Covid-19 vaccine. But they recently announced a change of plans: The inoculation program would instead start with healthcare workers, civil servants and the elderly. The government didn’t give a reason for the change, but the shifting procedures show some of the difficulties in coordinating a vaccine rollout for a massive nation spread across a string of islands.

Duration:00:15:52

How It All Started (Rebroadcast)

1/1/2021
On today’s special edition of the podcast, we’re revisiting one of our early episodes that took a close look at how the novel coronavirus lived before it entered humans and who it lived in. Bats are almost certainly the source of this pandemic, but these flying mammals may also hold the clues to stopping the next one. Bloomberg senior editor Jason Gale explores how research into bats led to the discovery of what could be the precursor of the novel coronavirus.

Duration:00:21:12

What We Know About Covid's Origins

12/30/2020
Scientists have long believed the source of the pandemic can be traced back to bats. Pioneering research by an Australian veterinarian named Dr. Hume Field more than 20 years ago showed why bats are an important host of some of humanity's most feared viruses. Bloomberg senior editor Jason Gale recently caught up with Hume to hear more about how the SARS-CoV-2 virus got from bats to people. Mentioned in this podcast: China Is Making It Harder to Solve the Mystery of How Covid Began

Duration:00:10:20

A New Technology Hiding in Covid Vaccines

12/23/2020
The approved COVID-19 vaccines developed by Moderna and the Pfizer and BioNTech partnership use genetic material called messenger RNA to effectively transform the body’s own cells into vaccine factories. This approach is a first for vaccines. It relies on decades of clinical research into whether messenger RNA technology can be used to treat a broad range of ailments, from cancer to the seasonal flu. Naomi Kresge explores whether the validation of this breakthrough technology during COVID-19...

Duration:00:15:01

Lessons From Past Vaccines

12/21/2020
The U.S. has begun a massive vaccination campaign to fight the coronavirus. But the effort will have plenty of challenges, including convincing people to get immunized. It’s not the first time the country has rolled out this kind of public health initiative. John Lauerman spoke with infectious-disease specialist William Schaffner of Vanderbilt University to learn more.

Duration:00:16:57

How Companies Are Lining Up Shots for Workers

12/18/2020
U.S. companies are taking some of the first concrete steps to prepare for the unprecedented and complex task of distributing hundreds of millions of doses to the American workforce. That means, for some: procuring deep-freezers to store vaccines or setting up health clinics at their facilities. Others are weighing whether to require vaccination for employees returning to in-person work. And, as Ryan Beene reports, several industries are lobbying to get their workers near the front of the...

Duration:00:16:06

Voices From the U.S. Vaccine Program

12/16/2020
Just one month ago, Iowa experienced its worst Covid-19 surge yet. Coronavirus cases began soaring there in early November, as they have throughout the United States. By the middle of the month, Iowa was recording about 4,000 new cases every day. But this week, staff at a University of Iowa Health Care system finally had reason to celebrate. The first doses of Pfizer’s vaccine arrived at the Iowa City location Monday morning, in tiny vials packed in dry ice. Angelica Lavito spoke to...

Duration:00:14:15

Louisiana's Vaccine Test Run

12/14/2020
As the first shots of the Covid-19 vaccines in the U.S. are administered, one of many big hurdles has yet to be cleared: States must transport and distribute the massive orders to the millions who need it. The state of Louisiana has been thinking about this problem for months. In November, they decided to test their vaccination strategy, using the flu vaccine. Angelica Lavito went to Shreveport as the project was unfolding, to find out what a mass vaccination looks like during a pandemic.

Duration:00:15:29

The Doctor Behind the Government's Vaccine Deals

12/11/2020
At the center of Operation Warp Speed, the Trump administration’s program to accelerate the development of Covid treatments and vaccines, is a man named Moncef Slaoui. Dr. Slaoui is chief scientific adviser for the Operation, and is trying to leverage decades of experience in the pharmaceutical industry to secure deals that can help curb the pandemic. Riley Griffin spoke to him about the possibility that his work might accelerate a treatment for the deadliest Covid-19 cases, a critical step...

Duration:00:16:09

Who Should Get the First Doses?

12/9/2020
The U.K. began administering the first Covid-19 vaccine this week, and the U.S. may do the same within days. But, the emergence of these vaccines brings tough choices around who gets it first and how it will be distributed. Bloomberg senior editor Jason Gale spoke with an ethics expert about the thinking behind some of these decisions and how the current vaccines could affect how we develop future ones.

Duration:00:13:35

A Turning Point Week Ahead

12/7/2020
The coming week could mark an early turning point in the U.S. battle against Covid-19. An advisory panel made up of top medical experts will meet December 10th to help the Food and Drug Administration review the drug for possible emergency authorization. That would clear the way to making it a top weapon against the virus. Reporter Anna Edney breaks down the next steps in the approval process, and helps explain the reality of making the vaccine available to the public.

Duration:00:12:48

The Struggle to Distribute the Vaccine

12/4/2020
Weeks before U.S. states expect to receive their first shipments of Covid-19 vaccines, they’re getting conflicting messages from the federal government about exactly how many doses may arrive. Some governors have made splashy announcements about how much of Pfizer and BioNTech’s vaccines they expect to get if the U.S. Food and Drug Administration authorizes them this month. Other states can’t provide a solid answer. But all of them must submit orders and distribution plans Friday. Reporter...

Duration:00:15:21

Biden’s Pandemic Response Overhaul

12/2/2020
One of Joe Biden’s first acts as president-elect was to announce a Covid-19 advisory board, putting the fight against the pandemic front and center in his presidential plans. On today's episode, a member of that advisory board talks to us about how a Biden White House plans to overhaul the government’s Coronavirus response.

Duration:00:16:11

A Bubble Made Up of Millions

11/30/2020
In Canada, the Covid-19 outbreak has affected much of the country. In Quebec, where three in five of Canada’s virus deaths have hit, rage over new lockdowns is palpable. In Ontario, ICUs are filling up. Out west, caseloads are hitting records. But four eastern Canadian provinces, comprising 2.4 million people, have banded together, barred outsiders, and hewed tightly to health guidelines. As a result, the region has a Covid-19 death rate that’s one tenth the rest of the country’s. With...

Duration:00:15:24

Business, Interrupted

11/27/2020
Today’s episode is a collaboration with Bloomberg Law. Hosted by David Schultz, this special investigative podcast examines how businesses of every stripe, large and small, assumed they had insurance that covered them in the event of a shutdown and how those assumptions were, by and large, wrong.

Duration:00:42:11